Jeffrey A. Schwaneke - 01 Apr 2026 Form 4 Insider Report for agilon health, inc. (AGL)

Reporting relationship: Chief Financial Officer
Issuer ticker: AGL
Reported as of: 01 Apr 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 03 Apr 2026, 19:40:29 UTC
Prior SEC filing: 13 Jan 2026
Next SEC filing: 02 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ Mimi Yang, as Attorney-in-Fact

Key filing fact

Jeffrey A. Schwaneke filed Form 4 for agilon health, inc. (AGL) on 03 Apr 2026.

Key facts

This page summarizes Jeffrey A. Schwaneke's Form 4 filing for agilon health, inc. (AGL).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 03 Apr 2026, 19:40.

Change

Previous filing in this sequence was filed on 13 Jan 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001446919 Primary reporting owner

Schwaneke Jeffrey A.

Relationship: Chief Financial Officer
Address: C/O AGILON HEALTH, INC., 440 POLARIS PARKWAY, SUITE 550, WESTERVILLE
Signature: /s/ Mimi Yang, as Attorney-in-Fact
Signature date: 03 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AGL transaction

Common Stock

Tax liability

Transaction value
Shares: -1,662
Change %: -2.5%
Price: $9.75^*
Shares after: 65,342
Date: 01 Apr 2026
Ownership: Direct
Footnotes: F1, F2

AGL transaction

Common Stock

Award

Transaction value
Shares: +75,000
Change %: +115%
Price: $0.000000^*
Shares after: 140,342
Date: 01 Apr 2026
Ownership: Direct
Footnotes: F3, F4

AGL holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 892
Date: 01 Apr 2026
Ownership: By trust
Footnotes: F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale.

Footnote F2

The amount of securities beneficially owned following the reported transaction reflects the 1 for 25 reverse stock split of the Issuer's issued and outstanding common stock effective March 30, 2026.

Footnote F3

Restricted stock units that vest in three equal installments on each anniversary of April 1, 2026, subject to continued employment.

Footnote F4

Includes restricted stock units.

Footnote F5

The amount of securities beneficially owned reflects the 1 for 25 reverse stock split of the Issuer's issued and outstanding common stock effective March 30, 2026.